Globe Life is expected to report Q3 2026 revenue of $1.56 billion and earnings per share of $4.87, with the stock currently trading at $168.77, roughly 11% below the average analyst price target of $189.56.
Investors are primarily focused on the growth of net life insurance premiums, particularly within the company's largest segment, American Income Life (AIL).
Management's ability to maintain agent recruitment and policy retention is under scrutiny following a period of regulatory and short-seller volatility earlier this year.
Analysts are also watching for the impact of the newly authorized $2.5 billion share buyback program and the contribution of higher net investment income to overall margins.